Patents by Inventor Olga Golonzhka

Olga Golonzhka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HDAC INHIBITORS FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY
    Publication number: 20210155593
    Abstract: The invention relates to HDAC inhibitors for use in the treatment of diabetic peripheral neuropathy in a subject in need thereof. Also provided herein are methods for treating diabetic peripheral neuropathy in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an HDAC inhibitor.
    Type: Application
    Filed: November 4, 2020
    Publication date: May 27, 2021
    Inventors: Olga Golonzhka, Matthew B. Jarpe
  • HDAC inhibitors for the treatment of diabetic peripheral neuropathy
    Patent number: 10858323
    Abstract: The invention relates to HDAC inhibitors for use in the treatment of diabetic peripheral neuropathy in a subject in need thereof. Also provided herein are methods for treating diabetic peripheral neuropathy in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an HDAC inhibitor.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: December 8, 2020
    Assignee: REGENACY PHARMACEUTICALS, LLC
    Inventors: Olga Golonzhka, Matthew B. Jarpe
  • HDAC INHIBITORS FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY
    Publication number: 20190106392
    Abstract: The invention relates to HDAC inhibitors for use in the treatment of diabetic peripheral neuropathy in a subject in need thereof. Also provided herein are methods for treating diabetic peripheral neuropathy in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an HDAC inhibitor.
    Type: Application
    Filed: July 3, 2018
    Publication date: April 11, 2019
    Inventors: Olga Golonzhka, Matthew B. Jarpe
  • HDAC inhibitors for the treatment of diabetic peripheral neuropathy
    Patent number: 10040769
    Abstract: The invention relates to HDAC inhibitors for use in the treatment of diabetic peripheral neuropathy in a subject in need thereof. Also provided herein are methods for treating diabetic peripheral neuropathy in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an HDAC inhibitor.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: August 7, 2018
    Assignee: REGENACY PHARMACEUTICALS, LLC
    Inventors: Olga Golonzhka, Matthew B. Jarpe
  • HDAC1/2 INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE AND/OR COGNITIVE DISORDERS
    Publication number: 20170240535
    Abstract: Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with HDAC activity, particularly diseases or disorders that involve activity of HDAC1 and/or HDAC2.
    Type: Application
    Filed: February 1, 2017
    Publication date: August 24, 2017
    Inventors: John H. van Duzer, Olga Golonzhka, Matthew B. Jarpe
  • HDAC INHIBITORS FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY
    Publication number: 20170114023
    Abstract: The invention relates to HDAC inhibitors for use in the treatment of diabetic peripheral neuropathy in a subject in need thereof. Also provided herein are methods for treating diabetic peripheral neuropathy in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an HDAC inhibitor.
    Type: Application
    Filed: October 27, 2016
    Publication date: April 27, 2017
    Inventors: Olga Golonzhka, Matthew B. Jarpe